ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $378,704 | -45.1% | 18,172 | -36.9% | 0.18% | -44.4% |
| Q2 2023 | $689,544 | -34.1% | 28,791 | -48.2% | 0.32% | -63.0% |
| Q1 2023 | $1,045,903 | +16.0% | 55,574 | -1.8% | 0.85% | +59.3% |
| Q4 2022 | $901,359 | +3.4% | 56,618 | +6.2% | 0.54% | +7.4% |
| Q3 2022 | $872,000 | +55.2% | 53,318 | +33.6% | 0.50% | +46.9% |
| Q2 2022 | $562,000 | -32.0% | 39,900 | +17.0% | 0.34% | -35.4% |
| Q1 2022 | $826,000 | +93.0% | 34,116 | +105.6% | 0.52% | +65.1% |
| Q1 2021 | $428,000 | -44.2% | 16,590 | +15.7% | 0.32% | -35.1% |
| Q4 2020 | $767,000 | +49.5% | 14,344 | +15.4% | 0.49% | +31.0% |
| Q3 2020 | $513,000 | +20.4% | 12,429 | +41.3% | 0.37% | +5.9% |
| Q2 2020 | $426,000 | – | 8,794 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |